CNTX - Context Therapeutics GAAP EPS of -$0.31
2023-08-10 14:26:07 ET
- Context Therapeutics press release ( NASDAQ: CNTX ): Q2 GAAP EPS of -$0.31.
- Cash and cash equivalents were $25.1 million at June 30, 2023, compared to $35.5 million at December 31, 2022.
For further details see:
Context Therapeutics GAAP EPS of -$0.31